New Drug Approvals Archive

Vanos (fluocinonide) Cream

Date of Approval: February 11, 2005
Company: Medicis
Treatment for: Psoriasis, Atopic Dermatitis, Dermatitis

Vanos (fluocinonide) is a corticosteroid (steroid hormone) approved to relieve the inflammation and itching caused by certain skin conditions that respond to treatment with corticosteroids in patients 12 years of age or older.

• Vanos Medicis - Treatment for Plaque-Type Psoriasis

Vanos (fluocinonide) FDA Approval History

Ammonul (sodium benzoate and sodium phenylacetate) Injection

Date of Approval: February 17, 2005
Company: Medicis
Treatment for: Hyperammonemia

Ammonul (sodium benzoate and sodium phenylacetate) is indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.

• Ammonul Medicis - Treatment for Urea Cycle Disorder

Ammonul (sodium benzoate and sodium phenylacetate) FDA Approval History

Cardura XL (doxazosin mesylate)

New Formulation Approved: February 22, 2005

• Cardura XL Pfizer Inc. - Treatment for Benign Prostatic Hyperplasia (BPH)

Cardura XL (doxazosin mesylate) FDA Approval History